Many studies have shown that the inhibition of Thr-55 phosphorylation of p53 protein not only can prevent the p53 protein from CRM binding and nucleocytoplasmic transportation but also can enhance the sensitivity of cancer cells to DNA damage [67,68]. This evidence concerns the gene TP53 and cancer.